News Website

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk - AAPNews Logo

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk AAPNews Logo

Published: Nov. 7, 2024, 11:37 p.m.

Read Full Article

Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer - OncLive

Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer OncLive

Published: Nov. 7, 2024, 8:04 p.m.

Read Full Article

Cancer genetic risk assessment guidelines expand to meet growing understanding of hereditary risk - EurekAlert

Cancer genetic risk assessment guidelines expand to meet growing understanding of hereditary risk EurekAlert

Published: Nov. 7, 2024, 3:18 p.m.

Read Full Article

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk - Kilgore News Herald

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk Kilgore News Herald

Published: Nov. 7, 2024, 1:34 p.m.

Read Full Article

B-Cell Protein Has Both Risk and Protective Factors in Endometrial Cancer - DocWire News

B-Cell Protein Has Both Risk and Protective Factors in Endometrial Cancer DocWire News

Published: Nov. 6, 2024, 7:14 p.m.

Read Full Article

Artificial intelligence-assisted magnetic resonance imaging technology in the differential diagnosis and prognosis prediction of endometrial cancer - Nature.com

Artificial intelligence-assisted magnetic resonance imaging technology in the differential diagnosis and prognosis prediction of endometrial cancer Nature.com

Published: Nov. 6, 2024, 5:27 a.m.

Read Full Article

Endometrial cancer survivor urges women to be their own health advocate - KEYE TV CBS Austin

Endometrial cancer survivor urges women to be their own health advocate KEYE TV CBS Austin

Published: Nov. 5, 2024, 4:42 p.m.

Read Full Article

Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens - OncLive

Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens OncLive

Published: Nov. 5, 2024, 3:07 p.m.

Read Full Article

New Trends of Endometrial Cancer Market To Receive Overwhelming - openPR

New Trends of Endometrial Cancer Market To Receive Overwhelming openPR

Published: Nov. 5, 2024, 2:36 p.m.

Read Full Article

Nouscom's Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to 'Intercept' Cancer - The Manila Times

Nouscom's Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to 'Intercept' Cancer The Manila Times

Published: Nov. 5, 2024, 2:11 p.m.

Read Full Article

Latest Articles

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk - AAPNews Logo

Dr Powell on the Implications of the FDA Approval of Dostarlimab for Endometrial Cancer - OncLive

Cancer genetic risk assessment guidelines expand to meet growing understanding of hereditary risk - EurekAlert

Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk - Kilgore News Herald

B-Cell Protein Has Both Risk and Protective Factors in Endometrial Cancer - DocWire News

Artificial intelligence-assisted magnetic resonance imaging technology in the differential diagnosis and prognosis prediction of endometrial cancer - Nature.com

Endometrial cancer survivor urges women to be their own health advocate - KEYE TV CBS Austin

Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens - OncLive

New Trends of Endometrial Cancer Market To Receive Overwhelming - openPR

Nouscom's Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to 'Intercept' Cancer - The Manila Times

Subscribe to Our Newsletter